Recent Updates — ACCV

Accelevation Holdings Corp.'s subsidiary entered into a new $650 million senior secured credit facility, consisting of a $250 million term loan and a $400 million revolving credit line. The transaction replaces the company's prior credit facilities established before its IPO. At closing, $250 million was drawn under the term loan and $150 million under the revolver. Proceeds were used to repay existing debt and pay transaction expenses. The new facilities mature in October 2031 and carry interest rates of SOFR plus 1.50% to 2.50%, a significant reduction from the previous spread of SOFR plus 4.50% to 5.25%. Bank of America serves as administrative agent.

Accelevation Holdings Corp. is a leading designer, manufacturer and installer of customized structural, electrical and mechanical systems for mission-critical infrastructure.

Accelevation Holdings Corp. closed its initial public offering on October 1, 2026, following the execution of an underwriting agreement on September 29, 2026. The company sold 10,000,000 shares and selling stockholders sold 20,000,000 shares at a public offering price of $18.00 per share. The underwriters also received a 30-day option to purchase up to an additional 4,500,000 shares. In connection with the IPO, the company issued 116,965,529 shares of Class B common stock to Investment Holdings and appointed seven new directors: Manu Bettegowda, Matt Bujor, Robert Morris, Paul Donahue, Howard Heckes, Ginger Jones, and Martin Durkin. The company also adopted amended bylaws and an omnibus incentive plan. Accelevation Holdings Corp. operates in the healthcare technology industry, providing solutions to accelerate patient access to medical treatments.